{"id":814395,"date":"2025-02-18T16:06:46","date_gmt":"2025-02-18T21:06:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/healthequity-reports-year-end-sales-metrics-2\/"},"modified":"2025-02-18T16:06:46","modified_gmt":"2025-02-18T21:06:46","slug":"healthequity-reports-year-end-sales-metrics-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/healthequity-reports-year-end-sales-metrics-2\/","title":{"rendered":"HealthEquity Reports Year-End Sales Metrics"},"content":{"rendered":"

\nAffirms Business Outlook, Announces Upcoming Events and Presentations
\n<\/h2>\n
\n

DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA”) custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January\u00a031, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations.<\/p>\n

The total number of HSAs as of January\u00a031, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January\u00a031, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January\u00a031, 2024. HSA Assets grew to $32.1 billion as of January\u00a031, 2025, an increase of 27% from $25.2 billion a year earlier.<\/p>\n

“Our ongoing investments in innovations helped Team Purple drive record results, breaking the one million new HSAs from sales ceiling and adding nearly $7 billion in HSA Assets in fiscal 2025,” said Scott Cutler, President and CEO of HealthEquity. “As we launch into fiscal 2026, we are focused on accelerating and extending our mission\u2019s reach to empower more healthcare consumers.”<\/p>\n

\n Total Accounts (unaudited)<\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n (in thousands, except percentages)<\/strong>\n <\/td>\n\n January 31, 2025<\/strong>\n <\/td>\n\n January 31, 2024<\/strong>\n <\/td>\n\n % Change<\/strong>\n <\/td>\n<\/tr>\n
HSAs<\/td>\n9,889<\/td>\n8,692<\/td>\n14%<\/td>\n<\/tr>\n
New HSAs from sales – Quarter-to-date<\/td>\n471<\/td>\n497<\/td>\n(5)%<\/td>\n<\/tr>\n
New HSAs from sales – Year-to-date<\/td>\n1,040<\/td>\n949<\/td>\n10%<\/td>\n<\/tr>\n
New HSAs from acquisitions – Year-to-date<\/td>\n616<\/td>\n\u2014<\/td>\n*<\/td>\n<\/tr>\n
HSAs with investments<\/td>\n753<\/td>\n610<\/td>\n23%<\/td>\n<\/tr>\n
CDBs<\/td>\n7,144<\/td>\n7,006<\/td>\n2%<\/td>\n<\/tr>\n
Total Accounts<\/td>\n17,033<\/td>\n15,698<\/td>\n9%<\/td>\n<\/tr>\n
Average Total Accounts – Quarter-to-date<\/td>\n16,677<\/td>\n15,318<\/td>\n9%<\/td>\n<\/tr>\n
Average Total Accounts – Year-to-date<\/td>\n16,302<\/td>\n15,105<\/td>\n8%<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not meaningful<\/p>\n

\n HSA Assets (unaudited)<\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n
\n (in millions, except percentages)<\/strong>\n <\/td>\n\n January 31, 2025<\/strong>\n <\/td>\n\u00a0<\/td>\n\n January 31, 2024<\/strong>\n <\/td>\n\u00a0<\/td>\n\n % Change<\/strong>\n <\/td>\n<\/tr>\n
HSA cash<\/td>\n$<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 17,435<\/td>\n\u00a0<\/td>\n$<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 15,006<\/td>\n\u00a0<\/td>\n16%<\/td>\n<\/tr>\n
HSA investments<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14,676<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 10,208<\/td>\n\u00a0<\/td>\n44%<\/td>\n<\/tr>\n
Total HSA Assets<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 32,111\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 25,214<\/td>\n\u00a0<\/td>\n27%<\/td>\n<\/tr>\n
Average daily HSA cash – Quarter-to-date<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 16,634<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14,210<\/td>\n\u00a0<\/td>\n17%<\/td>\n<\/tr>\n
Average daily HSA cash – Year-to-date<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 16,206<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14,071<\/td>\n\u00a0<\/td>\n15%<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

The following table summarizes the amount of HSA cash expected to reprice by fiscal year and the respective average annualized yield as of January\u00a031, 2025:<\/p>\n\n\n\n\n\n\n\n\n
\n Year ending January 31, (in billions, except percentages)<\/strong>\n <\/td>\n\n HSA cash expected to reprice<\/strong>\n <\/td>\n\u00a0<\/td>\n\n Average annualized yield<\/strong>\n <\/td>\n<\/tr>\n
2026<\/td>\n$<\/td>\n2.3<\/td>\n\u00a0<\/td>\n2.5%<\/td>\n<\/tr>\n
2027<\/td>\n\u00a0<\/td>\n4.1<\/td>\n\u00a0<\/td>\n1.9%<\/td>\n<\/tr>\n
2028<\/td>\n\u00a0<\/td>\n2.1<\/td>\n\u00a0<\/td>\n4.0%<\/td>\n<\/tr>\n
2029<\/td>\n\u00a0<\/td>\n1.5<\/td>\n\u00a0<\/td>\n3.6%<\/td>\n<\/tr>\n
Thereafter<\/td>\n\u00a0<\/td>\n6.6<\/td>\n\u00a0<\/td>\n4.4%<\/td>\n<\/tr>\n
Total (1)<\/td>\n$<\/td>\n16.6<\/td>\n\u00a0<\/td>\n3.4%<\/td>\n<\/tr>\n<\/table>\n

(1)\u00a0 Excludes $0.8 billion of HSA cash held in floating-rate contracts as of January\u00a031, 2025.<\/p>\n

\n Business outlook<\/strong>\n <\/p>\n

The Company affirmed its previously provided outlook for the fiscal year ended January 31, 2025 and the fiscal year ending January 31, 2026. Please see the Company\u2019s press release dated December 9, 2024 for details.<\/p>\n

\n Upcoming events and presentations<\/strong>\n <\/p>\n

The Company set the date for reporting its fourth quarter and fiscal year 2025 results.<\/p>\n\n\n\n\n\n\n\n\n
\n HealthEquity Fourth Quarter and Fiscal Year End 2025 Results Conference Call<\/u>
\n \n <\/td>\n<\/tr>\n
Date:<\/td>\nMarch 18, 2025<\/td>\n<\/tr>\n
Time:<\/td>\n4:30 p.m. Eastern Time \/ 2:30 p.m. Mountain Time<\/td>\n<\/tr>\n
Dial-In:<\/td>\n1-844-481-2556 (US and Canada) 1-412-317-0560 (International)<\/td>\n<\/tr>\n
Conference ID:<\/td>\nHealthEquity<\/td>\n<\/tr>\n
Webcast:<\/td>\nir.healthequity.com<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

The Company also announced that its management team plans to present and meet with investors at the following conference:<\/p>\n\n\n\n\n\n\n\n
\n Raymond James 46th Annual Institutional Investors Conference<\/u>
\n \n <\/td>\n<\/tr>\n
Location:\u00a0<\/td>\nJW Marriott Orlando Great Lakes<\/td>\n<\/tr>\n
Date:<\/td>\nMarch 4, 2025<\/td>\n<\/tr>\n
Time:<\/td>\n1:05 p.m. Eastern Time<\/td>\n<\/tr>\n
Webcast:<\/td>\nNone<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n About\u00a0HealthEquity<\/strong>\n <\/p>\n

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our vision of saving and improving the lives of healthcare consumers. For more information, visit www.healthequity.com.<\/p>\n

\n Forward-looking statements <\/strong>\n <\/p>\n

This press release contains and incorporates \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words \u201cmay,\u201d \u201cbelieves,\u201d \u201cintends,\u201d \u201cseeks,\u201d \u201caims,\u201d \u201canticipates,\u201d \u201cplans,\u201d \u201cestimates,\u201d \u201cexpects,\u201d \u201cshould,\u201d \u201cassumes,\u201d \u201ccontinues,\u201d \u201ccould,\u201d \u201cwill,\u201d \u201cfuture\u201d and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.<\/p>\n

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:<\/p>\n